Version 5.4
Mus musculus Protein: Trp53i13
Summary
InnateDB Protein IDBP-201625.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Trp53i13
Protein Name transformation related protein 53 inducible protein 13
Synonyms
Species Mus musculus
Ensembl Protein ENSMUSP00000057592
InnateDB Gene IDBG-201621 (Trp53i13)
Protein Structure
UniProt Annotation
Function May act as a tumor suppressor. Inhibits tumor cell growth, when overexpressed (By similarity). {ECO:0000250}.
Subcellular Localization Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}; Extracellular side {ECO:0000305}. Cytoplasm {ECO:0000250}. Note=Associates with unknown subcellular structures in the cytoplasm. {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0003674 molecular_function
Biological Process
GO:0008150 biological_process
Cellular Component
GO:0005575 cellular_component
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:1915125
InterPro
PFAM
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q5F267
PhosphoSite PhosphoSite-
TrEMBL B2RVS3
UniProt Splice Variant
Entrez Gene 216964
UniGene Mm.341211
RefSeq NP_001020091
MGI ID
MGI Symbol Trp53i13
OMIM
CCDS CCDS25081
HPRD
IMGT
EMBL AL591136 AL607072 AL645588 BC147324 BC147325 CH466596
GenPept AAI47325 AAI47326 CAI51871 CAI51995 CAI52029 EDL12887

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca